Denis Chem Lab Stock Screener | Share Price & Fundamental Analysis

DENISCHEM Pharmaceuticals
Screen Denis Chem Lab share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹80.00
▼ -2.11 (-2.57%)
2026-01-09 00:00:00
Market Cap ₹109.09 Cr.
P/B Ratio 1.23
EPS (TTM) ₹5.82
Dividend Yield 1.92%
Debt to Equity 0.01
52W High ₹157.20
52W Low ₹77.01
Operating Margin 10.00%
Profit Margin 3.98%
Revenue (TTM) ₹176.00
EBITDA ₹19.00
Net Income ₹7.00
Total Assets ₹112.00
Total Equity ₹85.00

Denis Chem Lab Share Price History - Stock Screener Chart

Screen DENISCHEM historical share price movements with interactive charts. Analyze price trends and patterns.

Denis Chem Lab Company Profile - Fundamental Screener

Screen Denis Chem Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DENISCHEM shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE051G01012

Denis Chem Lab Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen DENISCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 112 109 99 96 92 97 106 101 94 85
Current Assets 71 69 59 53 49 50 54 53 48 34
Fixed Assets 39 38 35 42 41 46 50 40 44 40
Liabilities
Total Liabilities 112 109 99 96 92 97 106 101 94 85
Current Liabilities 1 2 3 5 6 4 6 11 20 22
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 85 80 72 67 62 59 57 50 30 16
Share Capital 14 14 14 14 14 14 14 14 12 9
Reserves & Surplus 71 67 58 53 48 45 43 36 18 3
Screen DENISCHEM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 176 176 169 161 138 110 136 126 108 114 100 77
Expenses 157 157 147 142 122 99 121 110 95 100 91 68
EBITDA 19 19 23 19 15 11 15 16 13 15 9 10
Operating Profit % 10.00% 9.00% 13.00% 12.00% 11.00% 9.00% 11.00% 11.00% 11.00% 12.00% 9.00% 12.00%
Depreciation 5 7 7 8 6 6 7 6 6 7 6 4
Interest 4 1 1 1 1 2 3 3 5 6 7 5
Profit Before Tax 10 11 15 11 9 3 6 6 2 2 -3 0
Tax 2 3 4 3 3 1 2 0 0 1 1 0
Net Profit 7 8 11 8 6 2 4 6 2 1 -4 0
EPS 5.20 5.82 8.04 5.66 4.51 1.63 3.03 4.58 1.69 1.07 -4.92 0.09

Denis Chem Lab Cash Flow Screener - Liquidity Fundamentals

Screen DENISCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 12 18 16 17 8 13 8 11 7 21
Investing Activities -8 -15 -11 -10 -1 -2 -2 -16 -1 -13
Financing Activities -4 -4 -4 -7 -6 -14 -5 1 0 -7
Net Cash Flow 0 -1 1 0 1 -3 1 -4 5 1
Screen DENISCHEM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98%
FII Holding 0.00% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 27.41% 28.22% 28.90% 26.94% 26.88% 27.44% 27.86% 26.48%
Other Holding 33.61% 32.79% 32.12% 34.08% 34.14% 33.57% 33.16% 34.54%
Shareholder Count 7,218 7,227 7,304 4,834 6,021 6,857 7,385 3,493

Denis Chem Lab Dividend Screener - Share Yield Analysis

Screen DENISCHEM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Period Dividend Per Share Dividend Yield
2025-March ₹1.50 1.92%
2024-March ₹2.50 2.70%
2023-March ₹2.00 1.33%
2022-March ₹1.50 2.36%
2021-March ₹0.75 1.10%
2020-March ₹0.00 0.00%
2019-March ₹1.00 3.37%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%
2016-March ₹0.00 0.00%

Denis Chem Lab Index Membership - Market Screener Classification

Screen DENISCHEM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Denis Chem Lab is not part of any tracked indices.
Only major market indices are tracked in our system.

Denis Chem Lab Market Events Screener - Corporate Actions

Screen DENISCHEM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Dividend ₹ 1.50 /share -11.78%
Dividend ₹ 0.75 /share -3.52%
Dividend ₹ 1.50 /share 33.33%
Dividend ₹ 2.00 /share 34.35%
Dividend ₹ 2.50 /share -9.03%
Annual General Meeting NA -7.95%
Rights 2:11 -
Annual General Meeting NA -2.69%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -3.12%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -4.71%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 4.32%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -10.11%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -4.16%

Denis Chem Lab Competitors Screener - Peer Comparison

Screen DENISCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 421,299 40.53 54,729 9.71% 10,980 46.18
Divis Laboratories 171,931 69.57 9,712 18.67% 2,191 53.62
Torrent Pharmaceuticals 129,290 60.33 11,539 6.99% 1,911 62.04
Cipla 121,220 22.48 28,410 7.12% 5,291 44.91
Dr Reddys Laboratories 107,123 18.68 33,741 16.73% 5,725 60.09
Lupin 96,535 22.34 22,910 13.74% 3,306 60.88
Zydus Life Science 93,358 18.37 23,511 18.55% 4,615 47.29
Mankind Pharma 92,029 50.91 12,744 20.90% 2,007 53.62
Aurobindo Pharma 70,742 20.79 32,346 9.43% 3,484 57.50
Alkem Laboratories 66,921 27.88 13,458 3.70% 2,216 47.48

Denis Chem Lab Company Announcements - News Screener

Screen DENISCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2025-12-12 Closure of Trading Window View
2025-11-13 Results - Financial Results For Sep 30 2025 View
2025-11-13 Board Meeting Outcome for Board Meeting Outcome For - Submission Of Un-Audited Financial Results For The Quarter Ended On 30Th September 2025 View
2025-11-05 Board Meeting Intimation for For Taking On Record Unaudited Financial Results For The Quarter Ended On 30Th September 2025 View
2025-10-28 Announcement under Regulation 30 (LODR)-Credit Rating View
2025-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-09-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-09-26 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-26 Announcement Under Regulation 30 (LODR)- Updates (Intimation Of Appointment Of Secretarial Auditors Of The Company) View
2025-09-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-09-26 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-26 Announcement under Regulation 30 (LODR)-Meeting Updates View
2025-09-26 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-24 Closure of Trading Window View
2025-08-26 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-08-25 Announcement Under Regulation 30 (LODR) - Notice Of 44Th AGM Alongwith Annual Report 2024-25. View
2025-08-25 Shareholders Meeting - Annual Report 2024-25 Alongwith Notice Of 44Th AGM. View
2025-08-25 Reg. 34 (1) Annual Report. View
2025-08-13 Results- Financial Results For June 30 2025 View
2025-08-13 Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Unaudited Financial Results For The Quarter Ended On 30Th June 2025 View